Fenofibrate [orch, phsu]
Update [tmco]
Efficacy [qlco]
Management [ocac]
Dyslipidaemia [dsyn]
Fenofibrate [orch, phsu]
synthetic [acty]
isobutyric acid [orch]
Derivative [ftcn]
fibric acid [orch, phsu]
Derivative [ftcn]
Indicated [fndg]
treatment [ftcn]
Dyslipidaemia [dsyn]
Recently [tmco]
Tablet [bodm]
Formulation [resa]
Fenofibrate [orch, phsu]
Available [ftcn]
Bioavailability [qnco]
Old [tmco]
Capsule [bodm]
Formulation [resa]
FENOFIBRATE @ 160MG @ TABLET [clnd]
Bioequivalence [qlco]
Capsule [bodm]
Lipid [lipd]
MODIFY [ftcn]
Profile [lbpr]
Fenofibrate [orch, phsu]
Tablet [bodm]
Capsule [bodm]
Daily [tmco]
Decrease [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Total Cholesterol [lbpr]
Marked [qlco]
reduction [npop]
Plasma triglyceride level [lbpr]
High density lipoprotein cholesterol level [lbpr]
Fenofibrate [orch, phsu]
Capsule [bodm]
Daily [tmco]
Improvement [cnce]
Triglyceride [bacs, lipd]
High density lipoprotein cholesterol level [lbpr]
Simvastatin [orch, phsu]
mg day [qnco]
Pravastatin [orch, phsu]
mg day [qnco]
atorvastatin [orch, phsu]
mg day [qnco]
Combination Therapy [topp]
Fenofibrate [orch, phsu]
Capsule [bodm]
Daily [tmco]
fluvastatin [orch, phsu]
mg day [qnco]
atorvastatin 40 MG [clnd]
reductions [npop]
baseline [bodm]
Fenofibrate [orch, phsu]
Alone [qnco]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglyceride level [lbtr]
Seen [qlco]
Combination Therapy [topp]
Compared [acty]
Recipient [humn]
Fenofibrate [orch, phsu]
Capsule [bodm]
Daily [tmco]
Improvement [cnce]
baseline [bodm]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglyceride level [lbtr]
placebo [topp]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Double-Blind Study [resa]
Diabetes [dsyn]
Atherosclerosis [dsyn]
intervention [hlca]
Equal [qlco]
Angiography [diap]
Fenofibrate [orch, phsu]
progression [patf]
Coronary Atherosclerosis [dsyn]
placebo [topp]
Fenofibrate [orch, phsu]
Efficacy [qlco]
Patients [podg]
Metabolic syndrome [dsyn]
Patients [podg]
HIV infection [dsyn]
Protease Inhibitor [bacs, phsu]
Induced [ftcn]
Patients [podg]
Dyslipidaemia [dsyn]
secondary [neop]
Heart Transplantation [topp]
Fenofibrate [orch, phsu]
Well [qlco]
Clinical Trials [resa]
Large [qnco]
N NOS [aapp, imft]
Study [mnob]
Indicated [fndg]
gastrointestinal disorders [dsyn]
adverse events [fndg]
Fenofibrate [orch, phsu]
therapy [ftcn]
elevations [spco]
Transaminase [aapp, enzy]
creatine kinase levels [fndg]
Reported [inpr]
Rarely [qlco]
Fenofibrate [orch, phsu]
Fenofibrate [orch, phsu]
Lipid level [lbtr]
Patients [podg]
Primary [qlco]
Dyslipidaemia [dsyn]
Drug [phsu]
Efficacy [qlco]
Reducing [qlco]
Triglyceride level [lbtr]
High density lipoprotein cholesterol level [lbpr]
Fenofibrate [orch, phsu]
effective [qlco]
diabetic [fndg]
Dyslipidaemia [dsyn]
Improving [qlco]
Lipid level [lbtr]
Drug [phsu]
Reduced [qlco]
progression [patf]
Coronary Atherosclerosis [dsyn]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Large [qnco]
ONGOING [idcn]
Study [mnob]
Approximate [qlco]
Patients [podg]
Clarify [acty]
Lipid [lipd]
MODIFY [ftcn]
effects [qlco]
Fenofibrate [orch, phsu]
reduction [npop]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
